These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19817008)

  • 21. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia.
    George TP; Ziedonis DM; Feingold A; Pepper WT; Satterburg CA; Winkel J; Rounsaville BJ; Kosten TR
    Am J Psychiatry; 2000 Nov; 157(11):1835-42. PubMed ID: 11058482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The functional state of cultured peripheral blood lymphocytes from schizophrenic patients].
    Lideman RR
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 16(1):81-5. PubMed ID: 1258588
    [No Abstract]   [Full Text] [Related]  

  • 23. Atypical antipsychotic drugs, schizophrenia, and metabolic syndrome in non-Euro-American societies.
    Bou Khalil R
    Clin Neuropharmacol; 2012; 35(3):141-7. PubMed ID: 22592510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recommendations for the monitoring of serum concentrations of antipsychotic drugs in the treatment of schizophrenia.
    Lopez LV; Kane JM
    J Clin Psychiatry; 2015 Sep; 76(9):1249-50. PubMed ID: 26455671
    [No Abstract]   [Full Text] [Related]  

  • 25. A longitudinal study on the impact of antipsychotic treatment on serum leptin in schizophrenia.
    Venkatasubramanian G; Chittiprol S; Neelakantachar N; Shetty TK; Gangadhar BN
    Clin Neuropharmacol; 2010; 33(6):288-92. PubMed ID: 21060283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sertindole, a new atypical antipsychotic for the treatment of schizophrenia.
    Brown LA; Levin GM
    Pharmacotherapy; 1998; 18(1):69-83. PubMed ID: 9469684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia.
    Ferretjans R; de Campos SM; Ribeiro-Santos R; Guimarães FC; de Oliveira K; Cardoso AC; Araújo MS; Teixeira-Carvalho A; Martins-Filho OA; Teixeira AL; Salgado JV
    Schizophr Res; 2014 Jul; 156(2-3):254-60. PubMed ID: 24853061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Isolation of subpopulations of activated lymphocytes from the peripheral blood of schizophrenic patients].
    Prilipko LL; Kurilova II; Bogdanova ED; Vostrikova SA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(1):78-82. PubMed ID: 842230
    [No Abstract]   [Full Text] [Related]  

  • 29. Morphogenesis in blood lymphocytes stimulated with phytohaemagglutinin (PHA). A light and electron microscopic study.
    Biberfeld P
    Acta Pathol Microbiol Scand Suppl; 1971; 223():Suppl 223:1-70. PubMed ID: 4111740
    [No Abstract]   [Full Text] [Related]  

  • 30. Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: a cohort study.
    Bai YM; Chen TT; Yang WS; Chi YC; Lin CC; Liou YJ; Wang YC; Su TP; Chou P; Chen JY
    Schizophr Res; 2009 Jun; 111(1-3):1-8. PubMed ID: 19409756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Electron microscopy of lymphocytes in patients with acute paralytic ileus].
    Zaĭtsev VT; Boĭko VV; Zevzorov VP; Belen'kiĭ VP; Nevzorov OF
    Klin Khir; 2000; (2):16-9. PubMed ID: 10857280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics.
    Xiu MH; Hui L; Dang YF; Hou TD; Zhang CX; Zheng YL; Chen DC; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1508-12. PubMed ID: 19720106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation between estradiol and negative symptoms in men with schizophrenia.
    Kaneda Y; Ohmori T
    J Neuropsychiatry Clin Neurosci; 2005; 17(2):239-42. PubMed ID: 15939980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuro- and immunomodulatory steroids and other biochemical markers in drug-naive schizophrenia patients and the effect of treatment with atypical antipsychotics.
    Bicikova M; Hampl R; Hill M; Ripova D; Mohr P; Putz Z
    Neuro Endocrinol Lett; 2011; 32(2):141-7. PubMed ID: 21552193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Schizophrenia and immunity].
    Galinowski A; Levy-Soussan P; Lôo H
    Ann Med Psychol (Paris); 1992; 150(2-3):138-42. PubMed ID: 1364190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum cholesterol and treatment-resistance in schizophrenia.
    Boston PF; Dursun SM; Zafar R; Reveley MA
    Biol Psychiatry; 1996 Sep; 40(6):542-3. PubMed ID: 8879475
    [No Abstract]   [Full Text] [Related]  

  • 37. Lymphocytes in schizophrenic patients under therapy: serological, morphological and cell subset findings.
    Mazzarello V; Cecchini A; Fenu G; Rassu M; Dessy LA; Lorettu L; Montella A
    Ital J Anat Embryol; 2004; 109(3):177-88. PubMed ID: 15597918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum nitric oxide metabolite levels and the effect of antipsychotic therapy in schizophrenia.
    Taneli F; Pirildar S; Akdeniz F; Uyanik BS; Ari Z
    Arch Med Res; 2004; 35(5):401-5. PubMed ID: 15610909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression of peripheral blood lymphocytes may discriminate patients with schizophrenia from controls.
    Maschietto M; Silva AR; Puga RD; Lima L; Pereira CB; Nakano EY; Mello B; Gama CS; Belmonte-de-Abreu P; Carraro DM; Palha JA; Brentani H
    Psychiatry Res; 2012 Dec; 200(2-3):1018-21. PubMed ID: 22633013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Atypical lymphocytes in schizophrenic patients].
    Guo QY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1986 Jun; 19(3):185-7. PubMed ID: 3757639
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.